2017
Wright, G.E.B., Carleton, B., Hayden, M., Ross, C.J.D. The global spectrum of protein-coding pharmacogenomic diversity. Pharmacogenomics Journal. 2016 Oct 25. PMID: 27779249.
Drögemöller, B., Monzon, J.G., Bhavsar A., Borrie, A., Brooks, B., Wright, G.E., Liu, G., Fadhel, E., Renouf, D.J., Kollmannsberger, C.K. Bedard, P.L., Aminkeng, F., Amstutz, U., Hildebrand, C.A., Gunaretnam, E.P., Critchley, C., Chen, Z., Brunham, L.R., Ross, C.J.D*, Gelmon, K*, Carleton, B.C.* (* Shared co-senior authors). SLC16A5 genetic variation confers protection from cisplatin-induced ototoxicity in adult testicular cancer patients. JAMA Oncology. Accepted, in press. Feb. 2017
Lee, JJY van Karnebeek, CDM, Drögemoller, B., Shyr, C., Tarailo-Graovac, M., Eydoux, P., Ross, C.J., Wasserman, W.W., Björnson, B., Wu, J.K., Further validation of the SIGMAR1 c.151+1G>T mutation as cause of distal hereditary motor neuropathy. Child Neurology Open. (Accepted, In Press).
Kay, C, Tirado-Hurtado, I, Cornejo-Olivas, M., Collins, J.A., Wright, G., Inca-Martinez, M., Veliz-Otani, D., Ketelaar, M.E., Slama R.A., Ross, C.J., Mazzetti, P., Hayden, M.R. The Targetable A1 Huntington Disease Haplotype has Distinct Amerindian and European Origins in Latin America. European Journal of Human Genetics. 2017 Feb;25(3):332-340. PMID: 28000697
Tarailo-Graovac, M., Drögemöller, B., Wasserman, W., Ross, CJD, van den Ouweland, A., Darin, N., Kollberg, G., van Karnebeek, CD., Blomqvist, M., Identification of a large intronic transposal insertion in SLC17A5 causing sialic acid storage disease Orphanet Journal of Rare Diseases. 2017 Feb 10;12(1):28. PMID: 28187749
Aminkeng, F., Ross, CJD., Rassekh, SR., Rieder, MJ, Bhavsar, AP, Sanatani, S, Bernstein, D, Hayden, MR, Amstutz, U, Carleton, BC., Pharmacogenomic Screening for Anthracycline-induced Cardiotoxicity in Childhood Cancer. Br J Clin Pharm (In Press)
McMahon, K, Rassekh, SR, Schultz, KR, Pinsk, M, Blydt-Hansen, T, Mammen, C, Tsuyuki, RT, Devarajan, P, Cuvelier, GDE, Mitchell, LG, Baruchel, S, Palijan, A, Ross, CJD & Zappitelli, M. Design and Methods of the Pan-Canadian Applying Biomarkers to Minimize Long-Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Nephrotoxicity Study: A Prospective Observational Cohort Study. Cdn J Kidney Health & Disease. Feb 16, 2017 (In Press).
Armstrong L, Tarailo-Graovac M, Sinclair G, Seath KI, Wasserman WW, Ross CJ, van Karnebeek CD. A girl with developmental delay, ataxia, cranial nerve palsies, severe respiratory problems in infancy-Expanding NDST1 syndrome. Am J Med Genet. 2017 Mar;173(3):712-715.
2016
Tarailo-Graovac, M., Shyr, C., Ross, C.J., Horvath, G.A., Salvarinova, R., Ye, X., Zhang, L.H., Bhavsar, A.P., Drögemöller, B., Abdelsayed, M., Alfadhel, M., Armstrong, L., Baumgartner, M.R., Burda, P., Connolly, M.B., Cameron, J., Demos, M., Dewan, T., Dionne, J., Evans, M., Friedman, J.M., Garber, I., Lewis, S., Ling, J., Mandal, R., Mattman, A., McKinnon, M., Michoulas, A., Metzger, D., Ogunbayo, O.A., Rakic, B., Rozmus, J., Ruben, P., Sayson, B., Santra, S., Schultz, K.R., Selby, K., Shekel, P., Sirrs, S., Skrypnyk, C., Superti-Furga, A., Turvey, S.E., Van Allen, M.I., Wishart, D., Wu, J., Wu, J., Zafeiriou, D., Kluijtmans, L., Wevers, R.A., Eydoux, P., Lehman, A.M., Vallance, H., Stockler-Ipsiroglu, S, Sinclair, G., Wasserman, W.W., van Karnebeek, C.D. Exome sequencing and the management of neuro-metabolic disorders. New England Journal of Medicine; 374: 2246-2255. June 9, 2016.
van Karnebeek CD, Bonafé L, Wen XY, Tarailo-Graovac M, Balzano S, Royer-Bertrand B, Ashikov A, Garavelli L, Mammi I, Turolla L, Breen C, Donnai D, Cormier V, Heron D, Nishimura G, Uchikawa S, Campos-Xavier B, Rossi A, Hennet T, Brand-Arzamendi K, Rozmus J, Harshman K, Stevenson BJ, Girardi E, Superti-Furga G, Dewan T, Collingridge A, Halparin J, Ross CJ, Van Allen MI, Rossi A, Engelke UF, Kluijtmans LA, van der Heeft E, Renkema H, de Brouwer A, Huijben K, Zijlstra F, Heisse T, Boltje T, Wasserman WW, Rivolta C, Unger S, Lefeber DJ, Wevers RA, Superti-Furga A. NANS-mediated synthesis of sialic acid is required for brain and skeletal development. Nature Genetics. 2016 Jul;48(7):777-84. PMID: 27213289
Chan, SL, Samaranayake, N, Tiak Toh, M, Carleton, B, Teo, YY Dissanayake, VHW, Ross, CJD, Brunham, LR. Genetic Diversity of Pharmacogenomic Variants in Sri Lankan Populations: implications for clinical implementation. Pharmacogenet Genomics. 2016 Jan;26(1):28-39.
Madadi P, Kelly LE, Ross CJD, Kepron C, Edwards JN, Koren G. Forensic Investigation of Methadone Concentrations in Deceased Breastfed Infants. J Forensic Sci. 2016 Mar;61(2):576-80. PMID: 26513313
Langlois, S., Tarailo-Graovac, M., Sayson, B., Drogemoller, B., Swenerton, A., Ross, CJD, Wasserman, W., van Karnebeek, C. De novo dominant variants affecting the motor domain of KIF1A are a cause of PEHO syndrome. European Journal of Human Genetics. 2016 Jun;24(6):949-53.
Cohen AS, Yap DB, Lewis ME, Chijiwa C, Ramos-Arroyo MA, Tkachenko N, Milano V, Fradin M, McKinnon ML, Townsend KN, Xu J, Van Allen MI, Ross CJ, Dobyns WB, Weaver DD, Gibson WT. Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro. Hum Mutat. 2016 Mar;37(3):301-7. PMID: 26694085
Horvath, G.; Demos, M.; Shyr, C.; Matthews, A.; Zhang, L.; Race, S.; Stockler-Ipsiroglu, S.; Van Allen, M.; Mancarci, O.; Toker, L.; Pavlidis, P; Ross, CJD; Wasserman, W.; Trump, N.; Heales, S.; Pope, S., Cross, H.. Secondary neurotransmitter deficiencies in epilepsy caused by voltage-gated sodium channel mutations: a potential treatment target? Molecular Genetics & Metabolism. 2016 Jan;117(1):42-8.
Santra S, Cameron JM, Shyr C, Zhang L, Drögemöller B, Ross CJ, Wasserman WW, Wevers RA, Rodenburg RJ, Gupte G, Preece MA, van Karnebeek CD. Cytosolic phosphoenolpyruvate carboxykinase deficiency presenting with acute liver failure following gastroenteritis. Mol Genet Metab. 2016 May;118(1):21-7. PMID: 26971250
Lee JW, Pussegoda K, Rassekh RS, Monzon JG, Liu G, Hwang S, Bhavsar AP, Pritchard S, Ross CJ, Amstutz U, Carleton BC; & the CPNDS clinical recommendations group. Clinical Practice Recommendations For The Management And Prevention Of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers. Ther Drug Monit. 2016 Aug;38(4):423-31. PMID: 26960170
Anastasio N, Tarailo-Graovac M, Al-Khalifah R, Legault L, Drogemoller B, Ross CJ, Wasserman WW, van Karnebeek C, Buhas D. Mitochondrial Complex III Deficiency with Ketoacidosis and Hyperglycemia Mimicking Neonatal Diabetes. JIMD Rep. 2017. 31:57-62. PMID: 27074787
Wang, Z, Sadovnick AD, Traboulsee AL, Ross JP, Bernales CQ, Encarnacion M, Yee IM, de Lemos M, Greenwood T, Lee JD, Wright G, Ross CJ, Zhang S, Song W, Vilariño-Güell C. Nuclear Receptor NR1H3 in Familial Multiple Sclerosis. Neuron. 2016 Jun 1;90(5):948-54. PMID: 27253448
Aminkeng F, Ross CJ, Rassekh SR, Hwang S, Rieder MJ, Bhavsar AP, Smith A, Sanatani S, Gelmon KA, Bernstein D, Hayden MR, Amstutz U, Carleton BC; & the CPNDS Clinical Practice Recommendations Group. Recommendations for Genetic Testing to Reduce the Incidence of Anthracycline-induced Cardiotoxicity. Br J Clin Pharmacol. 2016 Sep;82(3):683-95.
Grossman I, Knappertz V, Laifenfeld D, Ross CJ, Zeskind B, Kolitz S, Ladkani D, Hayardeny L, Loupe P, Laufer R. Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research. Prog Neurobiol. 2016 Mar 4.
Wang CK, Aleksic A, Xu MS, Procyshyn RM, Ross CJ, Vila-Rodriguez F, Ramos-Miguel A, Yan R, Honer WG, Barr AM. A Tetra-Primer Amplification Refractory System Technique for the Cost-Effective and Novel Genotyping of Eight Single-Nucleotide Polymorphisms of the Catechol-O-Methyltransferase Gene. Genet Test Mol Biomarkers. 2016 May 26. [Epub ahead of print] PMID: 27228319
2015
Aminkeng, F & Bhavsar, A, Rassekh, SR, Brunham, L, Weissman, C, Lee, J, Visscher, H, Rieder, MJ, Bernstein, D, Carleton, BC, MR Hayden, Ross, CJD. A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nature Genetics. 2015 Sep; 47(9):1079-84.
Visscher, H., Rassekh, SR, Sandor, G, Caron, HN, van Dalen, EC, Kremer, LC, van der Pal, J, Brown, AMK, Phillips, M, Rogers, PC, Rieder, MJ, Carleton, BC, Hayden, MR, Ross, CJD. Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. J Pharmacogenomics. 2015;16(10):1065-76.
Smolina, K., Weymann, D., Morgan, S., Ross, CJD, Carleton, BC. Association between regulatory advisories and codeine prescribing to postpartum women. JAMA. 2015 May 12;313(18):1861-2.
Buxton, JA, Omura, J, Kuo, M, Ross, CJD, Tzemis, D, Purssell, R, Gardy, J, Carleton, B. Genetic determinants of cocaine-associated agranulocytosis. BMC Research Notes, 2015, 8:240. 1-6.
Kay C, Collins JA, Skotte NH, Southwell AL, Warby SC, Caron NS, Doty CN, Nguyen B, Griguoli A, Ross CJD, Squitieri F, Hayden MR. Huntingtin Haplotypes Provide Prioritized Target Panels for Allele Specific Silencing in Huntington Disease Patients of European Ancestry. Molecular Therapy. 2015 Nov;23(11):1759-71.
Tarailo-Graovac M, Sinclair G, Stockler-Ipsiroglu S, Van Allen M, Rozmus J, Shyr C, Biancheri R, Oh T, Sayson B, Lafek M, Ross CJ, Robinson WP, Wasserman WW, Rossi A, van Karnebeek CD. The genotypic and phenotypic spectrum of PIGA deficiency. Orphanet J Rare Dis. 2015. 27;10(1):23. PMID: 25885527.
Salvarinova, R., Ye, C., Rossi, A., Biancheri, R, Roland, EH., Pavlidis, P, Ross, CJD, Tarailo-Graovac, M, Wasserman, W, van Karnebeek, C. Expansion of the QARS deficiency phenotype with report of a family with isolated supratentorial brain abnormalities. Neurogenetics. 2015 Apr;16(2):145-9. PMID: 25432320
Baber M, Chaudhry S, Kelly L, Ross C, Carleton B, Berger H, Koren G. The pharmacogenetics of codeine pain relief in the postpartum period. Pharmacogenomics J. 2015 Oct;15(5):430-5.
Janer A, van Karnebeek CD, Sasarman F, Antonicka H, Al Ghamdi M, Shyr C, Dunbar M, Stockler-Ispiroglu S, Ross CJ, Vallance H, Dionne J, Wasserman WW, Shoubridge EA. RMND1 deficiency associated with neonatal lactic acidosis, infantile onset renal failure, deafness, and multi-organ involvement. Eur J Hum Genetics. 2015 Oct;23(10):1301-7. PMID: 25604853
Medeiros, M., Castañeda-Hernández, G., Ross, CJD, Carleton, B. Use of pharmacogenomics in pediatric renal transplant recipients. Frontiers in Genetics. 2015 Feb 18;6:41. PMID: 25741362
Shaw K, Amstutz U, Kim RB, Lesko LJ, Turgeon J, Michaud V, Hwang S, Ito S, Ross CJD, Carleton BC; Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin Therapy. Ther Drug Monit. 2015 Aug;37(4):428-36. PMID: 26186657
Wang, C, Xu, M, Lo, R, Procyshyn, R, Vila-Rodriguez, F, White, R, Ross, CJD, Honer, W, Barr, A Development of a cost-efficient novel method for rapid, concurrent genotyping of 5 common single nucleotide polymorphisms of the Brain Derived Neurotrophic Factor (BDNF) gene by Tetra-Primer Amplification Refractory System. International Journal of Methods in Psychiatric Research. 2015 Sep;24(3):235-44. PMID: 26118823.
Jiménez-Triana CA, Castelán-Martínez OD, Rivas-Ruiz R, Jiménez-Méndez R, Medina A, Clark P, Rassekh R, Castañeda-Hernández G, Carleton B, Medeiros M; Canadian Pharmacogenomics Network for Drug Safety Consortium (Ross, CJD). Cisplatin Nephrotoxicity and Longitudinal Growth in Children With Solid Tumors: A Retrospective Cohort Study. Medicine (Baltimore). 2015 Aug; 94(34): 1-7. PMID: 26313789
Sirrs S, van Karnebeek CD, Peng X, Shyr C, Tarailo-Graovac M, Mandal R, Testa D, Dubin D, Carbonetti G, Glynn SE, Sayson B, Robinson WP, Han B, Wishart D, Ross CJ, Wasserman WW, Hurwitz TA, Sinclair G, Kaczocha M. Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms. Orphanet J Rare Dis. 2015 Mar 28;10(1):38. PMID: 25885783
2014
Lee JW, Aminkeng F, Bhavsar AP, Shaw K, Carleton BC, Hayden MR, Ross CJ. The Emerging Era of Pharmacogenomics: Current Successes, Future Potential, and Challenges. Clin Genet. 2014 Mar 29. doi: 10.1111/cge.12392. [Epub ahead of print] PMID: 24684508
Rassekh, SR, & Ross, CJ. Cancer Pharmacogenomics in Children, chapter in “Cancer Genomics: From the Bench to Developing Personalized Medicine Approaches”. Edited by R. Arceci, J. Berman, and G. Dellaire. 2013.
Lam, J, Woodall, K, Solbeck, P, Ross CJD, Carleton BC, Hayden MR, Koren G, Madadi P. Codeine-related deaths in Ontario, Canada: The role of pharmacogenetics and drug interactions. Forensic Sci Int. 2014 Mar 26;239C:50-56. PMID: 24747667
Shaw, K, Amstutz, U, Hildebrand, C, Rassekh, SR, Hosking, M, Hayden, MR, Ross, CJD, Carleton, BC. VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children. Pediatrics Blood & Cancer.
2013
Kastelein, J, Ross, CJD, & Hayden, MR. The Road to Glybera: Discovery and Origins of the First Gene Therapy to Receive Regulatory Approval in the Western World. Hum Gene Ther. 2013 May;24(5):472-8. PMID: 23578007
Bhavsar AP, Brown NF, Stoepel J, Wiermer M, Martin DD, Hsu KJ, Imami K, Ross CJ, Hayden MR, Foster LJ, Li X, Hieter P, Finlay BB. The Salmonella Type III Effector SspH2 Specifically Exploits the NLR Co-chaperone Activity of SGT1 to Subvert Immunity. PLoS Pathog. 2013 Jul;9(7):e1003518. doi: 10.1371/journal.ppat.1003518. Epub 2013 Jul 25. PMID: 23935490
Shaw, K, Amstutz, U, Castro-P astrana, L, Loo, T, Ross, CJD, Hayden, MR, Carleton, BC. Pharmacogenomic investigation of adverse drug reactions (ADRs): the ADR prioritization tool, APT. Population Therapeutics, (Accepted March, 2013; In Press).
Rassekh SR, Ross CJ, Carleton BC, Hayden MR. Cancer pharmacogenomics in children: research initiatives and progress to date. Paediatr Drugs. 2013 Apr;15(2):71-81. PMID: 23529868
Amstutz U, Ross CJ, Castro-Pastrana LI, Rieder MJ, Shear NH, Hayden MR, Carleton BC; CPNDS Consortium. HLA-A*31:01 and HLA-B*15:02 as Genetic Markers for Carbamazepine Hypersensitivity in Children. Clin Pharmacol Ther. 2013 Jul;94(1):142-9. doi: 10.1038/clpt.2013.55. Epub 2013 Mar 18. PMID: 23588310
Aminkeng, F., Ross, CJD, Rassekh, SR, Brunham, LR, Sistonen, J, Dube, M-P, Ibrahim, M, Nyambo, TB, Omar, SA, Froment, A, Bodo, J-M, Tishkoff, S, Carleton, BC, Hayden, MR, and The Canadian Pharmacogenomics Network for Drug Safety Consortium. Higher Frequency of Genetic Variants Conferring Increased Risk for ADRs for Commonly Used Drugs Treating Cancer, AIDS and Tuberculosis in Persons of African Descent. The Pharmacogenomics Journal (Accepted February, 2013, In Press) PMID: 23588107
Visscher, H, Ross, CJD, Rassekh, SR, Sandor, G, Caron, HN, van Dalen, EC, Kremer, LC, van der Pal, J, Rogers, PC, Rieder, MJ, Carleton, BC, Hayden, MR, & the CPNDS consortium. Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatric Blood & Cancer. 2013 Aug;60(8):1375-81. PMID: 23441093
Pussegoda, K., Ross, CJD, Visscher, H., Yazdanpanah, M., Brooks, B., Rassekh, SR, Carleton, BC, Hayden, MR & the CPNDS Consortium. Replication of TPMT genetic variants highly associated with cisplatin-induced hearing loss in children. Clin. Pharmacol & Therapeutics (Accepted, In Press, April 2013) PMID: 23588304
Lam J, Kelly L, Matok I, Ross CJ, Carleton BC, Hayden MR, Madadi P, Koren G. Putative Association of ABCB1 2677G>T/A With Oxycodone-Induced Central Nervous System Depression in Breastfeeding Mothers. Ther Drug Monit. 2013 Jun 18. [Epub ahead of print] PMID: 23783165
Kelly, LE, Chaudhry, S.A., Rieder, MJ Jong, G, Moretti, ME, Lausman, A, Ross, CJ, Berger, H, Carleton, BC, Hayden, MR, Madadi, P, Koren, G. A Clinical Tool for Reducing Central Nervous System Depression among Neonates Exposed to Codeine through Breast Milk. published 29 Jul 2013 PLOS One (Accepted, In Press)
2012
Khetani JD, Madadi P, Sommer DD, Reddy D, Sistonen J, Ross CJ, Carleton BC, Hayden MR, Koren G. Apnea and oxygen desaturations in children treated with opioids after adenotonsillectomy for obstructive sleep apnea syndrome: a prospective pilot study. Paediatr Drugs. 2012 Dec 1;14(6):411-5. PMID: 23013460
Kelly, LE, Rieder, M, van den Anker, J, Malkin, B, Ross, CJD, Neely, M, Carleton, B, Hayden, M, Madadi, P, Koren, G. More Codeine Fatalities After Tonsillectomy in North American Children. Pediatrics. 2012 May;129(5):e1343-7.
Lam J, Matlow JN, Ross CJ, Hayden MR, Carleton BC, Madadi P. Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: the devil is in the details. Ther Drug Monit. 2012 Aug;34(4):378-80. PMID: 22777151
Sistonen, J, Madadi, P, Ross, CJD, Yazdanpanah, M, Lee, J, Landsmeer, M, Nauta, M, Carleton, BC, Koren, G, Hayden, MR. Prediction of opioid toxicity in neonates and their mothers using a novel combination of genetic markers. Clinical Pharmacology & Therapeutics. 2012 Apr;91(4):692-9. PMID: 22398969
Shaw, K., Amstutz, U., Jimenez-Mendez, R., Ross, CJD., Carleton, B.C. Suspected Opioid Overdose Case Resolved by CYP2D6 Genotyping. Therapeutic Drug Monitoring. 2012 Apr;34(2):121-3. PMID: 22406651
Visscher, H, Ross, CJD, Rassekh, R, Barhdadi, A, Dubé, MP, al-Saloos, H, Sandor, GS, Caron, HN, van Dalen, EC, Kremer, LC, van der Pal, HJ, Brown, AMK, Rogers, PC, Phillips, MS, Rieder, M, Carleton, BC, Hayden, MR, & the CPNDS consortium. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. Journal of Clinical Oncology. 30:1422-1428, 2012. PMID: 21900104
2011 - '09
Madadi, P, Joly Y, Avard, D, Chitayat, D, Smith, A, Ross, CJD, Carleton, B, Hayden, M, Koren, G. The communication of pharmacogenetic research results: Participants weigh in on their informational needs in a pilot study. J Popul Ther Clin Pharmacol;18:e152-5. 2011. PMID: 21467605
Vander Vaart, S, Berger, H, Madidi, P, Matok, L, Gijsen, V, de Wildt, S, Taddio, A, Sistonen, J, Ross, CJD, Carleton, BC, Hayden, MR, Koren, G, CYP2D6 polymorphisms and codeine analgesia in post partum pain management: a pilot study. Therapeutic Drug Monitoring. 2011 Aug;33(4):425-32. PMID: 21743374
Ross, CJD, Visscher, H., Rassekh, S.R., Castro-Pastrana, L., Shereck, E., Carleton, B.C., and Hayden, M.R. Pharmacogenomics of serious adverse drug reactions in pediatric oncology. Journal of Population Therapeutics and Clinical Pharmacology. J Popul Ther Clin Pharmacol. 2011;18:e134-51. PMID: 21467604
Brunham, L.R., Lansberg, P., Zhang, L., Miao, F., Carter, C., Hovingh, K., Jukema, W., Stalenhof, A., Ross, C.J.D., Kastelein, J.J.K, and Hayden, M.R. Differential Effect of the rs4149056 Variant in SLCO1B1 on Myopathy Associated with Simvastatin and Atorvastatin”. Pharmacogenomics J. 2011 Jan 18. 2011. PMID: 21243006
Madadi, P, Hildebrandt, D, Gong, I, Schwarz, U, Ciszkowski, C, Ross, C.J.D., Sistonen, J, Carleton, B, Hayden, MR, Lauwers, A, Koren, G. Fatal Hydrocodone Toxicity in a Child: Pharmacogenetics and Drug Interactions. Pediatrics. Oct;126(4):e986-9. 2010. PMID: 20837591
Madadi P, Joly Y, Avard D, Chitayat DC, Smith MA, Ross CJD, Carleton BC, Hayden MR, Koren G. Communicating Pharmacogenetic Research Results to Breastfeeding Mothers Taking Codeine: A Pilot Study of Perceptions and Benefits. Nat. Clin Pharmacol & Ther. Dec;88(6):792-5. 2010. PMID: 20739920
Ross CJD, Visscher H, Sistonen J, Brunham LR, Pussegoda K, Loo TT, Rieder MJ, Koren G, Carleton BC and Hayden MR and the CPNDS Consortium. The Canadian Pharmacogenomics Network for Drug Safety – A Model for Safety Pharmacology. Thyroid. 2010 Jul;20(7):681-7. PMID: 20578893
Ross, CJD, Katzov-Eckert, H, Dubé, MP, Brook, B, Rassekh, SR, Barhdadi, A, Feroz-Zadac, Y, Visscher, H, Brown, AMK, Rogers, PC, Phillips, MS, Carleton, B, Hayden, MR. TPMT and COMT genetic variants are predictive for severe hearing loss in children receiving cisplatin chemotherapy. Nature Genetics. 41, 1345 – 1349 Dec. 2009. PMID: 19898482
Visscher, H, Ross, CJD, Dubé, MP, Carleton, B, Hayden, MR. Application of principal component analysis to pharmacogenomic studies in Canada. J Pharmacogenomics. 2009 Dec;9(6):362-72. PMID: 19652663
Madadi, P, Ross, CJD, Hayden, MR, Carleton, BC, Gaedigk, A, Leeder, JS, Koren, G. Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control Study. Clinical Pharmacology & Therapeutics. 2009 Jan;85(1):31-5. PMID: 18719619.